Advances in antibody–drug conjugates: A new era of targeted cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in antibody–drug conjugates: A new era of targeted cancer therapy

Published:2017-10 Issue:10 Volume:22 Page:1547-1556
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Sau Samaresh,Alsaab Hashem O.,Kashaw Sushil Kumar,Tatiparti Katyayani,Iyer Arun K.

Funder

US National Institutes of Health/National Cancer Institute (NIH/NCI)

Wayne State University

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference76 articles.

1. Antibody-drug conjugates: an emerging class of cancer treatment;Diamantis;Br. J. Cancer,2016

2. Antibody-drug conjugates as novel anti-cancer chemotherapeutics;Peters;Biosci. Rep.,2015

3. Antibody therapy of cancer;Scott;Nat. Rev. Cancer,2012

4. Timeline: chemotherapy and the war on cancer;Chabner;Nat. Rev. Cancer,2005

5. Targeting multidrug resistance in cancer;Szakacs;Nat. Rev. Drug Discov.,2006

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation;Biochemical Pharmacology;2024-08

2. Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer;Journal of Experimental & Clinical Cancer Research;2024-07-25

3. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?;Journal of Medicinal Chemistry;2024-07-09

4. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics;Journal of Controlled Release;2024-07

5. VISTA‐targeted antibody‐drug conjugates exhibit potent antitumor effects on malignant pleural mesothelioma;MedComm – Oncology;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3